Fundraising Fox
/People
Sign in

Meg Krench

Investor

Investor at Sanofi Ventures

Cambridge, Massachusetts, United States

Find your path to Meg

1,058 people in our graph can introduce you to Meg.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Christopher Wolf to introduce you to Meg

You →Christopher · together at RA Capital (2016) →Meg

Ask Jamie Chen to introduce you to Meg

You →Jamie · 6 people · together at RA Capital →Meg

Ask Sam Okafor to introduce you to Meg

You →Sam · 5 people · together at Tufts University →Meg

Sign up to find every way you can get introduced to Meg

  • Your email: the people you already email who know Meg
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Meg
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Joined Sanofi Ventures in 2021 with a background in biotech investing and business development, previously with Vertex Pharmaceuticals' External Innovation team and RA Capital. Holds a Ph.D. in Neuroscience from MIT.

Invests in

AI & Machine LearningBiotechData & InfrastructureHealthtechMedical Devices

Experience

  1. SanofiInvestor, Sanofi Venturescurrent2021 — present
  2. Memento MedicinesDirectorcurrent2026 — present
  3. Korsana BiosciencesBoard Observercurrent2025 — present
  4. Draig TherapeuticsBoard Observercurrent2025 — present
  5. Eligo BioscienceDirectorcurrent2026 — present
  6. Eligo BioscienceBoard Observer2023 — 2026
  7. Stealth I&I platform companyBoard Observercurrent2023 — present
  8. QurAlisBoard Observercurrent2023 — present
  9. NormunityDirectorcurrent2025 — present
  10. NormunityBoard Observer2022 — 2025
  11. New England Venture NetworkBoard Co-Chair, Board Directorcurrent2019 — present
  12. VERALOX TherapeuticsDirector2021 — 2026
  13. Aliada TherapeuticsBoard Observer2022 — 2024
  14. Vertex PharmaceuticalsDirector of BD - External Innovation2020 — 2021Boston, Massachusetts, United States
  15. RA Capital Management, L.P.Senior Associate2018 — 2020Boston, MA
  16. RA Capital Management, L.P.Associate2016 — 2018Boston, Massachusetts
  17. CBT AdvisorsConsulting Intern2014 — 2016Cambridge, MA
  18. HDBuzzWriter2015 — 2016
  19. MIT MuseumInstructor2009 — 2016
  20. Massachusetts Institute of TechnologyNeuroscience PhD2009 — 2016
  21. Tufts UniversityVisiting lecturer2013 — 2016
  22. Scientific AmericanWriter2013

Skills & more

NeuroscienceMolecular BiologyResearchCell BiologyGeneticsScienceLaboratoryConfocal MicroscopyUniversity TeachingCommunity OutreachDrosophilaTechnical Writing
+12 moreCell CultureMicroscopyNews WritingCognitive NeuroscienceFluorescence MicroscopyMolecular GeneticsProtein ChemistryBiotechnologyCommunicationBiochemistryData AnalysisLife Sciences

From Meg's professional profile.

Investments

Per curated public sources.

Colleagues at Sanofi Ventures

Anne
Investor at Sanofi Ventures
Becca
Investor at Sanofi Ventures
Chris
Investor at Sanofi Ventures
Christopher Gagliardi
Principal at Sanofi Ventures
Cris De Luca
Partner, Digital at Sanofi Ventures
Francesc
Investor at Sanofi Ventures
Francesc Dosrius Lleonart
Associate Director of Investments at Sanofi Ventures
Jason
Investor at Sanofi Ventures

Frequently asked questions

Who is Meg Krench?
Joined Sanofi Ventures in 2021 with a background in biotech investing and business development, previously with Vertex Pharmaceuticals' External Innovation team and RA Capital. Holds a Ph.D. in Neuroscience from MIT.
Where does Meg Krench work?
Meg Krench is Investor at Sanofi Ventures.
What does Meg Krench invest in?
Meg Krench invests in AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech, Medical Devices.
What companies has Meg Krench invested in?
Investments tracked here include Memento Medicines.
Where did Meg Krench go to school?
Meg Krench studied at Massachusetts Institute of Technology (Doctor of Philosophy (PhD), Neuroscience); Penn State University (Bachelor of Science (BS), Biology).

Same school

Shared employers

Also worked at New England Venture Network1

Mary TobinPrincipal at Liberty Mutual Strategic Ventures